Alkem Laboratories Ltd. (ALKEM): Alkem Laboratories Share Price Hits Fresh 52-Week Low
- September 11, 2026
- Posted by: Harsh Piplani
- Category: News
Alkem Laboratories Share Price is Rs 5,089.50, down 0.41% today after hitting a fresh 52-week low of Rs 5,052.05. Market capitalisation stands at Rs 61,456.41 crore.
Alkem Laboratories Share Price fell to Rs 5,089.50 on 11 September 2026, down 0.41% from the previous close of Rs 5,110.20, after the stock touched a fresh 52-week low of Rs 5,052.05. The move puts the healthcare company, which has a market capitalisation of Rs 61,456.41 crore, firmly in today’s market conversation.
The supplied data confirms the price event, but it does not establish a company-specific catalyst for why the stock is falling today. That makes this a price-led Alkem Laboratories Stock News update rather than an event tied to any disclosed trigger in the dataset. Even so, a new one-year low often draws investor attention because it sharpens focus on valuation, profitability, sector positioning and peer comparison.
For readers tracking Alkem Laboratories Share Price Today, the key questions are straightforward: what exactly happened in the session, how does the current valuation compare with the Pharmaceuticals & Drugs benchmark, and what do the company’s profitability metrics suggest at this level. Univest examines those verified data points below without moving beyond the supplied numbers.
Alkem Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,089.5 |
| Previous Close | Rs 5,110.2 |
| Today's Move | Rs -20.7 (-0.41%) |
| Open | Rs 5,120.05 |
| High | Rs 5,123.1 |
| Low | Rs 5,052.05 |
| Turnover | Rs 0.97 crore |
| Market Capitalisation | Rs 61,456.41 crore |
Alkem Laboratories Ltd. (ALKEM) traded at Rs 5,089.5 versus the previous close of Rs 5,110.2, a fall of 0.41%. The stock opened at Rs 5,120.05, reached a high of Rs 5,123.1, touched a low of Rs 5,052.05.
Alkem Laboratories Share Price Today reflects a mild daily decline but an important technical milestone because the stock set a fresh 52-week trough at Rs 5,052.05. The session shows a weaker intraday structure, with the stock opening at Rs 5,120.05, rising to a day high of Rs 5,123.10 and then sliding to the day low before closing near that lower zone.
Against the previous close of Rs 5,110.20, the stock was down Rs 20.70, or 0.41%, at Rs 5,089.50. Turnover stood at Rs 0.97 crore, while market capitalisation remained Rs 61,456.41 crore. That combination matters because a fresh yearly low can become part of the day’s Stocks in News even when the percentage fall itself is not especially large.
In practical terms, the session suggests that sellers retained control after the open, with limited recovery from the day’s bottom. For anyone searching Alkem Laboratories Share Price Live or Alkem Laboratories Share Price Update, the verified takeaway is simple: the stock entered a new one-year low zone during today’s trade, keeping it on the radar in a Stock Market Today and Share Market Today context.
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 61,456.41 crore |
| P/E Ratio | 28.32x |
| P/B Ratio | 4.27x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.04% |
Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 28.32x, P/B 4.27x, ROE 18.29%, ROCE 21.28%. These figures provide context only and are not a buy or sell signal.
Alkem Laboratories Ltd. has a market capitalisation of Rs 61456.41 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.32x, P/B at 4.27x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 180.45, book value per share of Rs 1196.51, dividend yield of 1.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.91x, median ROE of 11.8%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 28.32x |
| Benchmark Median P/E | 32.91x |
| Benchmark Average P/E | 49.22x |
| Benchmark P/E Range | 3.4x to 701.57x |
| Company P/B Ratio | 4.27x |
| Benchmark Median P/B | 3.04x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.8% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.66% |
| Company Market Capitalisation | Rs 61,456.41 crore |
| Benchmark Median Market Cap | Rs 715.37 crore |
Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 28.32x, which is below the benchmark median of 32.91x, a difference of -13.95%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.8%, a difference of +55%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.66%, a difference of +55.78%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Biocon Ltd. | BIOCON | 64,372.92 | 128.32 | 1.87 | 1.35 | 3.26 |
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 68,850.12 | 37.94 | 6.22 | 14.1 | 20.35 |
| Abbott India Ltd. | ABBOTINDIA | 53,597.96 | 33.26 | 10.37 | 34.67 | 46.72 |
| Anthem Biosciences Ltd. | ANTHEM | 53,174.51 | 92.14 | 16.96 | 21.98 | 29.62 |
| Gland Pharma Ltd. | GLAND | 49,900.77 | 43.09 | 4.58 | 10.56 | 14.96 |
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 28.32x compared with the displayed peer median of 43.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 14.1% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 20.35%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 61,456.41 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories
- A fresh 52-week low of Rs 5,052.05 has put the stock among notable Market Movers and Stocks at 52 Week Low.
- Alkem Laboratories Share Price Today is Rs 5,089.50, down 0.41% from Rs 5,110.20, after opening at Rs 5,120.05.
- The stock’s P/E of 28.32 is below the same-industry median of 32.91, while ROE of 18.29% and ROCE of 21.28% are above benchmark levels.
- Market capitalisation of Rs 61,456.41 crore keeps the company relevant in sector-level and peer-level analysis.
- The supplied data confirms the price event, but does not identify a company-specific trigger, making verified metrics especially important.
About Alkem Laboratories
Alkem Laboratories Ltd. is part of the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. Based on the supplied company classification, the stock sits within one of India’s most closely watched defensive sectors, where investors typically compare companies using profitability ratios, valuation multiples and market capitalisation alongside price action.
Its scale is meaningful in this context. With a market cap of Rs 61,456.41 crore, Alkem is substantially larger than the industry median company and sits in the same broad size bracket as several major listed pharmaceutical peers. For readers following Alkem Laboratories Latest News, Alkem Laboratories Company News or Alkem Laboratories Earnings, that context matters because large-cap pharmaceutical stocks are often assessed not just on daily share price movement, but also on how efficiently they convert capital into returns. On the supplied data, ROE of 18.29% and ROCE of 21.28% keep the company relevant in that conversation.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Users tracking Alkem Laboratories Share Price can follow live share price trends, 52-week levels, market cap, valuation ratios and peer positioning on Univest. The platform also helps readers monitor Alkem Laboratories Shareholding Pattern, company financials, sector benchmarks and broader market insights in one place. For investors comparing Alkem Laboratories NSE and Alkem Laboratories BSE searches with a structured stock analysis view, Univest keeps the focus on verified numbers and context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Alkem Laboratories Share Price in focus today?
Ans. Alkem Laboratories Share Price is in focus because the stock touched a fresh 52-week low of Rs 5,052.05 during the session. It later traded at Rs 5,089.50, down 0.41%, putting the stock on investors’ radar.
What is Alkem Laboratories Share Price Today?
Ans. Alkem Laboratories Share Price Today is Rs 5,089.50. The stock was down Rs 20.70, or 0.41%, from the previous close of Rs 5,110.20 after trading between Rs 5,052.05 and Rs 5,123.10 in the session.
Did Alkem Laboratories hit a fresh 52-week low?
Ans. Yes, the stock hit a fresh 52-week low of Rs 5,052.05. That new one-year low is the key verified event in today’s Alkem Laboratories Stock News and is why the stock is being closely tracked.
What does today’s price action show for Alkem Laboratories?
Ans. The stock opened at Rs 5,120.05, touched a high of Rs 5,123.10 and fell to a low of Rs 5,052.05. Trading near Rs 5,089.50 later in the session indicates pressure after the early range.
What is the market capitalisation of Alkem Laboratories?
Ans. Alkem Laboratories has a market capitalisation of Rs 61,456.41 crore based on the supplied data. That places it well above the same-industry median market cap of Rs 715.37 crore and above the average of Rs 13,969.47 crore.
How is Alkem Laboratories valued compared with its industry?
Ans. Alkem trades at a P/E of 28.32 versus the same-industry median of 32.91 and average of 49.22. Its P/B of 4.27 is above the median of 3.04 but slightly below the average of 4.42.
How profitable is Alkem Laboratories on the supplied metrics?
Ans. The company’s ROE stands at 18.29% and ROCE at 21.28%. Both are above the same-industry median levels of 11.80% and 13.66%, showing stronger profitability than the benchmark on supplied figures.
What do EPS, book value and dividend yield indicate for Alkem Laboratories?
Ans. EPS is Rs 180.45, book value per share is Rs 1,196.51 and dividend yield is 1.04. Together, these figures provide context on earnings power, accounting net worth and historical payout relative to price.
How does Alkem compare with selected pharmaceutical peers?
Ans. Alkem’s P/E of 28.32 is lower than Biocon, Glenmark, Abbott India, Anthem Biosciences and Gland Pharma in the supplied peer set. Its profitability is stronger than some peers, though below Abbott India and Anthem on ROE and ROCE.
What should investors monitor next in Alkem Laboratories Stock News?
Ans. Investors can monitor whether Alkem Laboratories Share Price holds above the fresh 52-week low of Rs 5,052.05, while also tracking valuation versus peers, profitability metrics and future company financial trends on Univest.
